Bryant_Lab (@labbryant) 's Twitter Profile
Bryant_Lab

@labbryant

Academic Consultant Urological Surgeon. Prostate Cancer Research. CRUK/RCSEng Clinician Scientist Fellow. RT not endorsement. views my own.

ID: 1002095983487082496

linkhttps://www.nds.ox.ac.uk/team/richard-bryant calendar_today31-05-2018 07:54:35

262 Tweet

300 Takipรงi

227 Takip Edilen

๐™๐™ž๐™˜๐™˜๐™–๐™ง๐™™๐™ค ๐˜ฝ๐™š๐™ง๐™ฉ๐™ค๐™ก๐™ค MD PhD (@ricbertolo) 's Twitter Profile Photo

TRANSLATE trial presented by Richard Bryant during the game-changer session at #EAU25 Fantastic point underscored by Declan Murphy "A man does not have a prostate biopsy to avoid an infection; he has a prostate biopsy to find, or hopefully not find, clinically significant

TRANSLATE trial presented by Richard Bryant during the game-changer session at #EAU25

Fantastic point underscored by <a href="/declangmurphy/">Declan Murphy</a> 

"A man does not have a prostate biopsy to avoid an infection; he has a prostate biopsy to find, or hopefully not find, clinically significant
Eric Barret (@barret_e) 's Twitter Profile Photo

Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial - TP = greater detection of GGG 2 or higher disease

๐™๐™ž๐™˜๐™˜๐™–๐™ง๐™™๐™ค ๐˜ฝ๐™š๐™ง๐™ฉ๐™ค๐™ก๐™ค MD PhD (@ricbertolo) 's Twitter Profile Photo

Roberto Declan Murphy European Association of Urology (EAU) In fact, I think this is exactly what he meantโ€ฆ We should not downplay these trials just because they did not ultimately find a significant advantage in the infection rate. We should view them positively because, especially the latest one, it demonstrated an increase in the

OCTRU Trials Hub (@octructu) 's Twitter Profile Photo

TRANSLATE Trial have published their results paper in The Lancet Oncology! Well done to all involved, and thank you to everyone who took part! ๐Ÿ‘ Full paper: doi.org/10.1016/S1470-โ€ฆ News article summary: ox.ac.uk/news/2025-03-2โ€ฆ #ProstateCancerAwarenessMonth #OpenAccess

<a href="/TranslateTrial/">TRANSLATE Trial</a> have published their results paper in The Lancet Oncology! 

Well done to all involved, and thank you to everyone who took part! ๐Ÿ‘

Full paper: doi.org/10.1016/S1470-โ€ฆ

News article summary: ox.ac.uk/news/2025-03-2โ€ฆ

#ProstateCancerAwarenessMonth #OpenAccess
University of Oxford (@uniofoxford) 's Twitter Profile Photo

Researchers from around the UK, led by Oxford University, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients. Find out more โฌ‡๏ธ

Researchers from around the UK, led by Oxford University, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.

Find out more โฌ‡๏ธ
Aquilant Urology (@aquilanturology) 's Twitter Profile Photo

Huge congratulations to Mr Abhishek Sharma & NHS Lothian on their first #NanoKnife #IRE case for intermediate risk #prostatecancer. Thank you to Mr Marc Laniardo for proctoring. It's been an absolute pleasure to support the set up of this life-changing service #focaltherapy

Huge congratulations to Mr Abhishek Sharma &amp; <a href="/NHS_Lothian/">NHS Lothian</a> on their first #NanoKnife #IRE case for intermediate risk #prostatecancer. Thank you to Mr Marc Laniardo for proctoring. It's been an absolute pleasure to support the set up of this life-changing service #focaltherapy
National Institute for Health and Care Research (@nihrresearch) 's Twitter Profile Photo

Results from the #NIHRfundedย TRANSLATE Trial, published in the The Lancet Oncology provide new evidence regarding the two currently available common techniques for prostate biopsy, to better inform urologists and patients of the relative trade-offs between the two techniques.

Maidstone and Tunbridge Wells NHS Trust (@mtwnhs) 's Twitter Profile Photo

Consultant Urological Surgeon, Mr Hide Yamamoto (@hideyamaurol) and researchers from around the UK taking part in TRANSLATE Trial have found a new way of performing prostate biopsies is safer and more effective at diagnosing prostate cancer. Read more: ow.ly/Mt2e50Vu2N5

Consultant Urological Surgeon, Mr Hide Yamamoto (@hideyamaurol) and researchers from around the UK taking part in <a href="/TranslateTrial/">TRANSLATE Trial</a> have found a new way of performing prostate biopsies is safer and more effective at diagnosing prostate cancer.

Read more: ow.ly/Mt2e50Vu2N5
Milos Grujic (@grujicmilos10) 's Twitter Profile Photo

๐Ÿšจ Just published in The Lancet Oncology! ๐Ÿ“Œ The #TRANSLATEtrial shows that LATP biopsy detects more clinically significant prostate cancer than TRUS (60.1% vs 54.4%; OR 1.32, p=0.031). ๐Ÿงฌ Lower infection risk ๐Ÿ“Š Comparable complications ๐Ÿ˜– Slightly more pain reported ๐Ÿ”—

๐Ÿšจ Just published in <a href="/TheLancetOncol/">The Lancet Oncology</a>!
๐Ÿ“Œ The #TRANSLATEtrial shows that LATP biopsy detects more clinically significant prostate cancer than TRUS (60.1% vs 54.4%; OR 1.32, p=0.031).
๐Ÿงฌ Lower infection risk
๐Ÿ“Š Comparable complications
๐Ÿ˜– Slightly more pain reported

๐Ÿ”—
Bryant_Lab (@labbryant) 's Twitter Profile Photo

A big day for the PART_Trial 100 recruited participants, a significant way towards our required sample size, with the aim of delivering level 1 evidence for #focaltherapy versus #radicaltreatment for #prostatecancer National Institute for Health and Care Research SITU Oxford QuinteT OCTRU Trials Hub